Neumora Therapeutics (NASDAQ:NMRA – Get Free Report) is projected to issue its Q4 2025 results before the market opens on Monday, March 2nd. Analysts expect Neumora Therapeutics to post earnings of ($0.34) per share for the quarter. Parties can find conference call details on the company’s upcoming Q4 2025 earning report for the latest details […]

Sealed Air (NYSE:SEE – Get Free Report) is anticipated to release its Q4 2025 results before the market opens on Monday, March 2nd. Analysts expect the company to announce earnings of $0.72 per share and revenue of $1.3426 billion for the quarter. Parties may visit the the company’s upcoming Q4 2025 earning results page for […]

Ocular Therapeutix (NASDAQ:OCUL – Get Free Report) is expected to issue its Q4 2025 results before the market opens on Monday, March 2nd. Analysts expect Ocular Therapeutix to post earnings of ($0.33) per share and revenue of $16.1280 million for the quarter. Interested persons may visit the the company’s upcoming Q4 2025 earning results page […]

PMV Pharmaceuticals (NASDAQ:PMVP – Get Free Report) is expected to be issuing its Q4 2025 results before the market opens on Monday, March 2nd. Analysts expect the company to announce earnings of ($0.40) per share for the quarter. Individuals are encouraged to explore the company’s upcoming Q4 2025 earning overview page for the latest details […]

Scholar Rock (NASDAQ:SRRK – Get Free Report) is expected to be posting its Q4 2025 results before the market opens on Tuesday, March 3rd. Analysts expect the company to announce earnings of ($0.86) per share for the quarter. Interested persons are encouraged to explore the company’s upcoming Q4 2025 earning overview page for the latest […]

Avadel Pharmaceuticals (NASDAQ:AVDL – Get Free Report) is projected to release its Q4 2025 results before the market opens on Monday, March 2nd. Analysts expect Avadel Pharmaceuticals to post earnings of $0.09 per share for the quarter. Interested persons can find conference call details on the company’s upcoming Q4 2025 earning report page for the […]

Limbach (NASDAQ:LMB – Get Free Report) is projected to issue its Q4 2025 results after the market closes on Monday, March 2nd. Analysts expect the company to announce earnings of $1.26 per share and revenue of $197.5610 million for the quarter. Investors may review the information on the company’s upcoming Q4 2025 earning report for […]